Fri, Oct 04, 2024
Navratna SIP By Anil Singhvi, Stock To Buy For Long Term: The stock market has been quite volatile and Sensex dropped 354.67 points to 82,142.43 in early trade and Nifty declined 114.1 points to 25,136.
More >
Thu, Jul 04, 2024
Zydus Lifesciences Share Price Target: Anil Singhvi has advised investors to buy this pharma stock when it is available in the range of Rs 1,100.
Lupin shares saw significant rise on Thursday after brokerage double uprgraded it to 'add'. It has given 12-month target of Rs 1,805 for the stock.
Wed, Dec 06, 2023
Aclaris Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel drugs for immuno-inflammatory diseases.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
